FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)

Clinical and Experimental Immunology

Volumn 187, Issue 1, 2017, Pages 138-145

  Jolles, S ^a   Carne, E ^a   Brouns, M ^b   El Shanawany, T ^a   Williams, P ^a   Marshall, C ^a   Fielding, P ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b NEVILL HALL HOSPITAL   (United Kingdom)

Author keywords

common variable immunodeficiency; fluorodeoxyglucose positron emission tomography; granulomatous lymphocytic interstitial lung disease; rituximab

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BETA 2 MICROGLOBULIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; RITUXIMAB; STEROID;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW BIOPSY; BRONCHIECTASIS; CASE REPORT; CELL COUNT; COMMON VARIABLE IMMUNODEFICIENCY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CRACKLE; DRUG MEGADOSE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FORCED VITAL CAPACITY; GAS DIFFUSION; GLUCOSE BLOOD LEVEL; GRANULOMATOUS LYMPHOCYTIC INTERSTITIAL LUNG DISEASE; HUMAN; HUMAN TISSUE; IMAGING SOFTWARE; IMMUNE THROMBOCYTOPENIA; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG STRUCTURE; LYMPHADENOPATHY; MEMORY CELL; METABOLIC PARAMETERS; MIDDLE AGED; NATURAL KILLER CELL; PET-CT SCANNER; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPLENECTOMY; SPLENOMEGALY; STEROID THERAPY; THROMBOCYTOPENIA; TOTAL LUNG CAPACITY; TREATMENT RESPONSE; VERRUCA VULGARIS; DIAGNOSTIC IMAGING; EVALUATION STUDY; GRANULOMA, RESPIRATORY TRACT; IMMUNOLOGY; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; TREATMENT OUTCOME; X-RAY COMPUTED TOMOGRAPHY;

ADULT; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOMA, RESPIRATORY TRACT; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTES; MIDDLE AGED; MYCOPHENOLIC ACID; POSITRON-EMISSION TOMOGRAPHY; RITUXIMAB; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 85006160341     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12856     Document Type: Article

References (37)

1. Jolles S. The variable in common variable immunodeficiency: a disease of complex phenotypes. J Allergy Clin Immunol Pract 2013; 1:545–56.
2. Chapel H, Lucas M, Lee M et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 2008; 112:277–86.
3. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood 2012; 119:1650–7.
4. Prasse A, Kayser G, Warnatz K. Common variable immunodeficiency-associated granulomatous and interstitial lung disease. Curr Opin Pulm Med 2013; 19:503–9.
5. Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol 2013; 174:203–11.
6. Bonilla FA, Barlan I, Chapel H et al. International consensus document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract 2016; 4:38–59.
7. Thon V, Martinez N, Kanariou M, Warnatz K, Quinti I, Chapel H. Common variable immunodeficiency disorders (CVID) – clinical diagnostic criteria: esid.org/Working-Parties/Registry/Diagnosis-criteria, 2014. Accessed August 2016.
8. Park JE, Beal I, Dilworth JP, Tormey V, Haddock J. The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency. Eur J Radiol 2005; 54:359–64.
9. Bouvry D, Mouthon L, Brillet PY et al. Granulomatosis-associated common variable immunodeficiency disorder: a case–control study versus sarcoidosis. Eur Respir J 2013; 41:115–22.
10. Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol 2004; 114:415–21.
11. Pathria M, Urbine D, Zumberg MS, Guarderas J. Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency. BMJ Case Rep 2016; 2016. doi:10.1136/bcr-2016-215624.
12. Tashtoush B, Memarpour R, Ramirez J, Bejarano P, Mehta J. Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency. Clin Respir J 2016. doi: 10.1111/crj.12511.
13. Verma N, Grimbacher B, Hurst JR. Lung disease in primary antibody deficiency. Lancet Respir Med 2015; 3:651–60.
14. Chase NM, Verbsky JW, Hintermeyer MK et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 2013; 33:30–9.
15. Vaidyanathan S, Patel CN, Scarsbrook AF, Chowdhury FU. FDG PET/CT in infection and inflammation–current and emerging clinical applications. Clin Radiol 2015; 70:787–800.
16. Cheson BD, Fisher RI, Barrington SF et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32:3059–68.
17. Scarsbrook AF, Barrington SF. PET-CT in the UK: current status and future directions. Clin Radiol 2016; 71:673–90.
18. Mannina A, Chung JH, Swigris JJ et al. Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease. Ann Am Thorac Soc 2016; 13:1042–9.
19. Burton CM, Milman N, Andersen CB, Marquart H, Iversen M. Common variable immune deficiency and lung transplantation. Scand J Infect Dis 2007; 39:362–7.
20. Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. Q J Med 2002; 95:655–62.
21. Maglione PJ, Overbey JR, Cunningham-Rundles C. Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings. J Allergy Clin Immunol Pract 2015; 3:941–50.
22. Arumugakani G, Wood PM, Carter CR. Frequency of Treg cells is reduced in CVID patients with autoimmunity and splenomegaly and is associated with expanded CD21lo B lymphocytes. J Clin Immunol 2010; 30:292–300.
23. Bateman EA, Ayers L, Sadler R et al. T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections. Clin Exp Immunol 2012; 170:202–11.
24. Carter CR, Aravind G, Smalle NL, Cole JY, Savic S, Wood PM. CVID patients with autoimmunity have elevated T cell expression of granzyme B and HLA-DR and reduced levels of Treg cells. J Clin Pathol 2013; 66:146–50.
25. Chapel H, Lucas M, Patel S et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol 2012; 130:1197–98.
26. Giovannetti A, Pierdominici M, Mazzetta F et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol 2007; 178:3932–43.
27. Gregersen S, Aalokken TM, Mynarek G et al. Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors. Ann Allergy Asthma Immunol 2010; 104:503–10.
28. Horn J, Manguiat A, Berglund LJ et al. Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 2009; 156:446–54.
29. Malphettes M, Gerard L, Carmagnat M et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis 2009; 49:1329–38.
30. Melo KM, Carvalho KI, Bruno FR et al. A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLOS ONE 2009; 4:e6269.
31. Quinti I, Soresina A, Guerra A et al. Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol 2011; 31:315–22.
32. Wehr C, Kivioja T, Schmitt C et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111:77–85.
33. Milito C, Pulvirenti F, Serra G et al. Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies. J Clin Immunol 2015; 35:491–500.
34. Serra G, Milito C, Mitrevski M et al. Lung MRI as a possible alternative to CT scan for patients with primary immune deficiencies and increased radiosensitivity. Chest 2011; 140:1581–9.
35. Wong GK, Huissoon AP. T-cell abnormalities in common variable immunodeficiency: the hidden defect. J Clin Pathol 2016; 69:672–6.
36. STILPAD Observational Study. Available at: https://www.uniklinik-freiburg.de/cci/studien/stilpad.html. Accessed August 2016.
37. van de Ven AA, Warnatz K. The autoimmune conundrum in common variable immunodeficiency disorders. Curr Opin Allergy Clin Immunol 2015; 15:514–24.